From: The role of FOLFIRINOX in metastatic pancreatic cancer: a meta-analysis
FOLFIRINOX vs. control | No. of studies | RR | 95%CI | p | Heterogeneity (I2) |
---|---|---|---|---|---|
Any grade about neuropathy | 6 | 1.12 | 0.60–2.10 | 0.72 | 83 |
Any grade anemia | 8 | 0.95 | 0.59–1.52 | 0.84 | 94 |
Any grade decreased appetite | 3 | 1.58 | 1.08–2.30 | 0.02 | 78 |
Any grade diarrhea | 6 | 2.72 | 1.60–4.61 | <0.001 | 74 |
Any grade fatigue | 5 | 1.25 | 0.92-1.71 | 0.16 | 70 |
Any grade febrile neutropenia | 4 | 2.19 | 1.04–4.65 | 0.04 | 25 |
Any grade mucositis | 2 | 3.84 | 2.33–6.34 | <0.001 | 0 |
Any grade nausea | 4 | 1.94 | 1.16–3.24 | 0.01 | 46 |
Any grade neutropenia | 8 | 1.15 | 0.86–1.52 | 0.35 | 90 |
Any grade thrombocytopenia | 7 | 0.76 | 0.42–1.36 | 0.36 | 92 |
Any grade vomiting | 4 | 1.63 | 1.26–2.09 | <0.001 | 0 |
Any grade white blood cell decrease | 2 | 1.54 | 1.16–2.04 | 0.003 | 6 |
Grade 3 or higher about neuropathy | 7 | 0.85 | 0.33–2.18 | 0.73 | 62 |
Grade 3 or higher anemia | 9 | 1.21 | 0.73–2.03 | 0.46 | 31 |
Grade 3 or higher decreased appetite | 2 | 1.41 | 0.56–3.57 | 0.47 | 0 |
Grade 3 or higher diarrhea | 8 | 3.74 | 1.62–8.62 | 0.002 | 54 |
Grade 3 or higher elevated ALT | 3 | 0.38 | 0.21–0.68 | 0.001 | 0 |
Grade 3 or higher fatigue | 6 | 0.95 | 0.62–1.45 | 0.80 | 35 |
Grade 3 or higher febrile neutropenia | 6 | 2.84 | 1.35–5.99 | 0.006 | 30 |
Grade 3 or higher mucositis | 2 | 1.34 | 0.71–2.51 | 0.37 | NA |
Grade 3 or higher nausea | 4 | 3.60 | 1.26–10.30 | 0.02 | 11 |
Grade 3 or higher neutropenia | 8 | 1.67 | 1.14–2.46 | 0.009 | 87 |
Grade 3 or higher thrombocytopenia | 9 | 1.20 | 0.74–1.93 | 0.47 | 18 |
Grade 3 or higher vomiting | 6 | 1.46 | 1.07–1.98 | 0.02 | 0 |
Grade 3 or higher white blood cell decrease | 2 | 3.09 | 2.00–4.77 | <0.001 | 0 |
Death | 2 | 0.49 | 0.20–1.23 | 0.13 | 0 |